Monopar Therapeutics Inc MNPR

Name: Monopar Therapeutics Inc
SKU: MNPR
Price: 70.37 USD
Availability: InStock

‎$‎70.37-0.28(-0.40%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Strong Buy

Price Target

130.33

Based on analysts who covered MNPR

Invest in Monopar Therapeutics Inc
Today

Create an eToro account to buy MNPR stock on a secure, user-friendly, multi-asset trading platform.

Buy MNPR

Monopar Therapeutics Inc MNPR

Nuernberger Beteiligungs AG

Molson Coors Beverage Co

‎$‎44.47

+4.54%

BONEX.ST

Bonesupport Holding AB

MAX

*Past performance is not an indication of future results

Jump to:

About MNPR >
How to Buy? >
Top Guides >

The Monopar Therapeutics Inc share price today is ‎$‎70.37, reflecting a ‎-0.40‎% change over the last 24 hours and ‎1.56‎% over the past week. The current market capitalization of MNPR is ‎$‎487.17M with an average volume in the last three months of 194998.29. The stock has a P/E ratio of -31.05 and a dividend yield of 0%. With the stock’s beta sitting at 1.48

Market Cap

‎$‎487.17M

Day’s Range

‎$‎68.39 - ‎$‎71.54

52W Range

‎$‎50 - ‎$‎124.42

Average Volume (3M)

194998.29

Price-Earnings Ratio

-31.05

Revenue

‎$‎0

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎70.65

EPS

‎$‎-2.34

Beta

1.48

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Monopar Therapeutics Inc (MNPR) page and place an order to buy Monopar Therapeutics Inc.

Buy MNPR

Looking for more information? Check out our guide on Academy.

Monopar Therapeutics Inc is a US-based clinical-stage biopharmaceutical company dedicated to developing innovative treatments. Its primary aim is to address significant unmet medical needs across oncology and severe infectious diseases, focusing on novel drug candidates.

Operating within the biotechnology and pharmaceutical sector, Monopar Therapeutics Inc concentrates on advancing a pipeline of investigational therapies. Its work aims to provide new treatment options that could potentially improve outcomes for patients battling life-threatening conditions.

Monitor the MNPR share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

Chandler Drew Robinson, MD, MBA

Employees

Founded

2014

Wilmette, Illinois, US

Med Tech NASDAQ

Get Started

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

What Is Leverage and Margin?

How do leverage and margin work? We explain what leverage is and how investors can use margin and leverage to increase their buying power.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

Go to the Academy >

Invest in Monopar Therapeutics Inc
Today

Create an eToro account to buy MNPR stock on a secure, user-friendly, multi-asset trading platform.

Get Started

What is the current price of Monopar Therapeutics Inc stock?

The current price of MNPR is ‎$‎70.37.

What is Monopar Therapeutics Inc’s stock future price target?

The average price target for Monopar Therapeutics Inc is ‎$‎130.33. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Monopar Therapeutics Inc?

Analysts offer forecasts for Monopar Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Monopar Therapeutics Inc?

The market capitalisation of Monopar Therapeutics Inc is ‎$‎487.17M

Is Monopar Therapeutics Inc stock buy, sell or hold?

Based on 6 analysts offering recommendations for MNPR in the last 3 months, the overall consensus is Strong Buy.